Molecular Biomarkers in Drug-Induced Liver Injury: Challenges and Future Perspectives

• Prif Awduron: Siyu Fu (Awdur), Dongbo Wu (Awdur), Wei Jiang (Awdur), Juan Li (Awdur), Jiang Long (Awdur), Chengyao Jia (Awdur), Taoyou Zhou (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Frontiers Media S.A., 2020-01-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Drug-induced liver injury (DILI) is one among the common adverse drug reactions and the leading causes of drug development attritions, black box warnings, and post-marketing withdrawals. Despite having relatively low clinical incidence, its potentially severe adverse events should be considered in t...